河南医学研究
河南醫學研究
하남의학연구
HENAN MEDICAL RESEARCH
2015年
3期
27-28
,共2页
氯吡格雷%短暂性脑缺血发作%疗效
氯吡格雷%短暫性腦缺血髮作%療效
록필격뢰%단잠성뇌결혈발작%료효
clopidogrel%transient ischemic attack%curative effect
目的:研究低剂量国产氯吡格雷治疗70岁以上短暂性脑缺血发作患者的疗效及安全性。方法选取176例70岁以上短暂性脑缺血发作患者,随机分为低剂量国产氯吡格雷治疗组(泰嘉,89例)与进口氯吡格雷对照组(波立维,87例)。两组氯吡格雷初始剂量均为75 mg/d,14 d 后治疗组剂量调整为50 mg/d,两组疗程均为3个月。观察两组患者治疗效果及不良反应发生情况。结果治疗组有效率为65.17%,对照组有效率66.67%,差异无统计学意义(P >0.05)。两组治疗过程中均未发现明显出血倾向及胃肠道反应患者。结论低剂量国产氯吡格雷治疗70岁以上短暂性脑缺血发作患者效果较好,安全性高,与进口氯吡格雷相当,值得临床推广。
目的:研究低劑量國產氯吡格雷治療70歲以上短暫性腦缺血髮作患者的療效及安全性。方法選取176例70歲以上短暫性腦缺血髮作患者,隨機分為低劑量國產氯吡格雷治療組(泰嘉,89例)與進口氯吡格雷對照組(波立維,87例)。兩組氯吡格雷初始劑量均為75 mg/d,14 d 後治療組劑量調整為50 mg/d,兩組療程均為3箇月。觀察兩組患者治療效果及不良反應髮生情況。結果治療組有效率為65.17%,對照組有效率66.67%,差異無統計學意義(P >0.05)。兩組治療過程中均未髮現明顯齣血傾嚮及胃腸道反應患者。結論低劑量國產氯吡格雷治療70歲以上短暫性腦缺血髮作患者效果較好,安全性高,與進口氯吡格雷相噹,值得臨床推廣。
목적:연구저제량국산록필격뢰치료70세이상단잠성뇌결혈발작환자적료효급안전성。방법선취176례70세이상단잠성뇌결혈발작환자,수궤분위저제량국산록필격뢰치료조(태가,89례)여진구록필격뢰대조조(파립유,87례)。량조록필격뢰초시제량균위75 mg/d,14 d 후치료조제량조정위50 mg/d,량조료정균위3개월。관찰량조환자치료효과급불량반응발생정황。결과치료조유효솔위65.17%,대조조유효솔66.67%,차이무통계학의의(P >0.05)。량조치료과정중균미발현명현출혈경향급위장도반응환자。결론저제량국산록필격뢰치료70세이상단잠성뇌결혈발작환자효과교호,안전성고,여진구록필격뢰상당,치득림상추엄。
Objective To study the efficacy and safety of low -dose domestic clopidogrel in the treatment of patients with transient ischemic attack over 70 years old.Methods 176 patients with transient ischemic attack over 70 years old were selected and randomly divided into treatment group (low -dose domestic clopidogrel,89 cases)and control group (imported clopidogrel,87 cases).The ini-tial doses of clopidogrel in both two groups were 75 mg/d.The dose of low -dose domestic clopidogrel was adjusted to 50 mg/d after 14 days’treatment.Two groups were treated for 3 months.The curative effect and adverse reactions in two groups were observed.Results The effective rates of treatment group and control group were 65.17% and 66.67%,and the difference was not statistically significant (P >0.05).There was no patient with obvious bleeding tendency and gastrointestinal reaction in the course of treatment in the two groups.Conclusion Low -dose domestic clopidogrel had a good efficacy and high safety in the treatment of patients with transient is-chemic attack over 70 years old,same as imported clopidogrel.It deserves the clinical expansion.